INDV Insider Filing: Barry Patrick CCO Restricted Stock Units May 20, 2026

Insider trading filings reveal what company leaders really think about their stock. When executives file ownership documents, it signals confidence or caution. Today we examine a significant filing from INDV leadership. Barry Patrick, Chief Commercial Officer at Indivior Pharmaceuticals Inc, filed an initial ownership report on January 7, 2026. This filing discloses 130,312 restricted stock units held by the executive. The filing provides insight into executive compensation and long-term incentive structures at the pharmaceutical company.

Barry Patrick’s Restricted Stock Unit Filing

Barry Patrick serves as Chief Commercial Officer at Indivior Pharmaceuticals Inc. On January 7, 2026, he filed an initial ownership report with the SEC. This Form 3 filing disclosed 130,312 restricted stock units in his name.

Restricted stock units represent a form of executive compensation. They vest over time and convert to common shares. This filing marks Patrick’s first ownership disclosure with the company.

Understanding Form 3 Initial Ownership Filings

Form 3 filings are initial ownership reports required when insiders join a company. The SEC requires officers to disclose all securities they own within 10 days of appointment. This filing type establishes a baseline for tracking future transactions.

Patrick’s filing shows 130,312 restricted stock units as his initial holding. The transaction date listed is June 2, 2028, indicating when the RSUs were granted. Form 3 filings do not indicate buys or sells, only ownership positions.

What Restricted Stock Units Mean for Executives

Restricted stock units are equity awards that align executive interests with shareholders. They typically vest over three to four years based on continued employment. Once vested, RSUs convert to actual company shares.

The 130,312 units represent significant compensation for Patrick’s role. At Indivior’s current market cap of $4.6 billion, this holding demonstrates substantial executive stake. RSU grants encourage long-term commitment to company performance and strategy.

Insider Activity and Market Implications

This filing represents an initial ownership disclosure rather than a buy or sell transaction. The SEC filing establishes Patrick’s baseline holdings for future monitoring. Meyka AI rates INDV a grade of B+, reflecting solid fundamentals and sector positioning.

Initial ownership filings help investors track executive compensation structures. They provide transparency into how leadership is incentivized. This filing shows Indivior uses equity compensation to retain key commercial talent.

Final Thoughts

Barry Patrick’s initial ownership filing reveals Indivior Pharmaceuticals uses restricted stock units to compensate and retain executive talent. The 130,312 RSU grant demonstrates meaningful equity alignment for the Chief Commercial Officer role. This filing establishes a baseline for tracking Patrick’s future transactions and provides investors with transparency into executive compensation practices at the pharmaceutical company.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.